<DOC>
	<DOCNO>NCT02266511</DOCNO>
	<brief_summary>The objective study determine bioequivalence two batch Flomax® 0.4 mg capsule healthy male subject . One commercial scale batch produce Nishine facility , batch , equal size , produce Norman II facility</brief_summary>
	<brief_title>Study Assess Bioequivalence Two Batches Tamsulosin Hydrochloride Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Tamsulosin</mesh_term>
	<criteria>Provide write informed consent , evidence signature Informed Consent Form approve investigational review board ( IRB ) follow full explanation nature purpose study Be healthy male race 18 40 year age Have body weight within 10 % normal sex , height , frame specify Body Weight Nomogram Inclusion/Exclusion Criteria Have clinically significant abnormality basis medical history , physical examination , vital sign significant orthostatic blood pressure change , define 20 mm Hg drop systolic blood pressure assume maintain stand position 3 minute supine least 5 minute . There clinically significant symptom associate orthostatic blood pressure test procedure Have cardiovascular system within normal limit base history , physical examination , 12lead electrocardiogram ( ECG ) Have negative test ethanol breathalyzer Have ability understand requirement study , agree abide study restriction , agree return require assessment Require ambulatory assistance ( e.g. , canes walker ) Have history `` first dose hypotensive episode '' upon start therapy alphablocker Have history pathological fall ( unintentional change body position ) last year occur circumstance normal homeostatic mechanism would ordinarily maintain stability syncope Have medical laboratory abnormality ( liver function test , blood urea nitrogen , creatinine outside reference range clinical laboratory ) . Any subject enters study laboratory abnormality must approve Medical Monitor prior enrollment Have abnormal alpha1acid glycoprotein value ( i.e. , value great 120 mg/dL ) Have history acute angina attack prior 6 month Have abnormality ECG history document myocardial infarction ( electrocardiographic change , serum enzyme increase , hospitalization ) prior 6 month , evidence myocardial infarction ECG Have New York Heart Association 's Functional Classification Heart Failure Class I , II , III , IV Have prior history endocarditis Use prescription medication within 2 week dose , overthecounter concomitant therapy exception vitamin , dietary supplement , acetaminophen within 7 day dose Have use investigational drug within 1 month ( 30 day ) Screening Period visit Donated blood within 1 month enter study Have know history follow : Clinically significant renal disease ( renal dysfunction ; i.e. , creatinine great equal 2.0 mg/dL ) Severe cardiovascular disease ( coarctation aorta , severe cardiac failure , second third degree heart block , severe angina ) Pulmonary disease ( chronic lung disease emphysema degree could cause functional abnormality right heart ) Have acute illness ( e.g. , acute upper respiratory infection ) within 2 week prior start study Have medical condition might interfere either absorption , distribution , metabolism , excretion tamsulosin Have history illness allergy , opinion Investigator , might confound result study pose additional risk administer Flomax® subject Have history liver disease physical finding suggestive liver disease Have smoke within last 3 month know suspected alcohol abuser illicit drug user within past year , positive urine drug screen Exhibit , opinion Investigator , sign symptoms immunodeficiency syndrome , whether spontaneously acquire , congenital , iatrogenic ( These syndrome characterize unusual susceptibility infection [ bacterial , viral , fungal ] , occurrence autoimmune disease , lymphoreticular malignancy ) Have calculate creatinine clearance le 90 mL/min base upon follow formula : Creatinine Clearance = ( 140 age year ) ( weight kg ) / ( 72 ) ( serum creatinine ) Have history cancer except nonmelanoma skin cancer treat excision</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>